The 2012 US Coagulation Market

March 2012 | 424 pages | ID: U2206449720EN
Venture Planning Group

Abstracts

This report presents a comprehensive analysis of the US coagulation market, including:

• Major issues pertaining to the US coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
• Ten-year volume and sales forecasts for 40 coagulation procedures performed in US hospitals, commercial laboratories, and physician offices, including typical coagulation daily work loads.
• Placement estimates for major automated and semiautomated systems.
• Review of current instrumentation technologies, and a feature comparison of nearly 50 leading analyzers.
• Ten-year reagent and instrument sales forecasts.
• Sales and market shares of leading reagent and instrument suppliers.
• Review of coagulation technologies and their potential market applications.
• Major opportunities for coagulation instruments and consumables.
• Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
• Business opportunities and strategic recommendations for instrument and reagent suppliers.

Contains 424 pages and 18 tables

Contents

WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major Routine and Special Coagulation Tests
  1. Introduction
  2. Activated Partial Thromboplastin Time (APTT)
  3. Alpha-2 Antiplasmin
  4. Antithrombin III
  5. Bleeding Time
  6. D-Dimer
  7. Ethanol Flocculation Test
  8. Euglobulin Lysis
  9. Factor Assays
    a. Introduction
    b. Factor II
    c. Factor V/Factor V Leiden
    d. Factor VII
    e. Factor VIII
    f. Factor IX
    g. Factor IXa
    h. Factor X (Stuart Factor)
    i. Factor Xa
    j. Factor XI
    k. Factor XII
    l. Factor XIII
  10. Fibrin Degradation Products
  11. Fibrinogen
  12. Heparin
  13. Hirudin
  14. Hypercoagulability and Thrombosis
  15. Lipoprotein a
  16. Plasmin
  17. Plasminogen
  18. Plasminogen Activator Inhibitor (PAI)
  19. Platelet Function Tests
  20. Platelet Aggregation
  21. Proteins C and S
  22. Prothrombin Fragment 1.2
  23. Prothrombin Time (PT)
  24. Reptilase Time
  25. Thrombin Time
  26. Tissue-Type Plasminogen Activator (t-PA)
  27. Von Willebrand's Factor
B. Instrumentation Review
    - Introduction
    - Benk Hemolab
    - Benk TRT Thrombotimer
    - Bio/Data MCA 310
    - Bio/Data MCA 210
    - Bio/Data PAP-4C D/4D/4C
    - Cardiovascular Diagnostics COAG
    - Diagnostica Stago STA Compact
    - Diagnostica Stago STA-R
    - Diagnostica Stago Star 4/8
    - Helena Laboratories Cascade 480
    - Helena Laboratories Cascade M
    - Helena Laboratories PACKS-4
    - Helena THOR
    - Instrumentation Laboratory ACL 100 and 1000 series
    - Instrumentation Laboratory ACL6000
    - Instrumentation Laboratory ACL7000
    - Instrumentation Laboratory ACL9000
    - Instrumentation Laboratory Electra 1000C
    - Instrumentation Laboratory Electra 1400C
    - Instrumentation Laboratory Electra 1600/C
    - Instrumentation Laboratory Electra 1800C
    - Instrumentation Laboratory Futura
    - ITC Hemochron 8000
    - Roche Diagnostics CoaguChek
    - Siemens BCS
    - Siemens BCT
    - Siemens BF II/Fibrintimer Series
    - Sysmex CA-50
    - Sysmex CA-500
    - Sysmex CA-1500
    - Sysmex CA-5000/CA-1000
    - Sysmex CA-6000
    - Sysmex CA-7000
    - Teco Coatron II/Jr./AccuStasis 5000
    - Trinity Biotech Amax CS190
    - Trinity Biotech Amax CS400
    - Trinity Biotech Coag-A-Mate Max
    - Trinity Biotech KC 40, 4A, 1A Series
    - Trinity Biotech MDA 180
    - Trinity Biotech Coag-A-Mate MTX
    - Trinity Biotech Coag-A-Mate RA4
    - Trinity Biotech Coag-A-Mate XC/Plus
    - Trinity Biotech Coag-A-Mate XM
C. Major in Vitro Diagnostic Technologies and Their Potential Applications
  1. Chromogenic Substrates
  2. Monoclonal and Polyclonal Antibodies
  3. Immunoassays
    a. Applications
    b. Technological Principle
    c. Enzyme Immunoassays (EIA)
    - Overview
    - ELISA
    - EMIT
    - Dot Immunobinding Assays
    - Capillary Immunoassays
    - Enzyme Amplification
    - Electrochemical Immunoassay
    d. Fluorescent Immunoassays
    - Fluorescence Polarization
    - Time-Resolved Pulse Fluorescence
    - Fluorescence Lifetime
    e. Latex Agglutination
    f. Immunoprecipitation
  4. Microcomputers
  5. Automation
  6. Robotics
  7. DNA Probes
    a. Overview
    b. Amplification Methods
    - PCR
    - Ligase Chain Reaction
    - Branched DNA
    - Q-Beta Replicase
    - NASBA
    - SDA
    - 3 SR
    - HPA
    - Two-Tiered System
    - LAT
  8. Artificial Intelligence
  9. Dry Chemistry 10. Biosensors
D. Worldwide Market Overview
  1. Business Environment
  2. Market Structure
  3. Market Size and Growth
  4. POC Testing Market

USA

A. Executive Summary
B. Business Environment
  1. Health Care Expenditures
  2. Cost Consciousness
  3. Industry Consolidation
  4. Managed Care
  5. Hospitals
  6. Admissions
  7. Length of Stay
  8. Industry Diversification
  9. Physician Demographics
  10. Population Aging
    a. Chronic Illnesses
    b. Disease Incidence
    c. Susceptibility to Iatrogenesis
    d. Multiple Illness Cases
  11. Laboratory Regulations
C. Market Structure
  1. Centralized Testing
    a. Hospitals
    b. Commercial laboratories
  2. Decentralized Testing
    a. Physician Offices/Group Practices
    b. Point-of-Care Testing
    c. Home/Self Testing
    d. Other Decentralized Testing Locations
D. Market Size, Growth And Major Suppliers

MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types Of Distributors
  7. Market Segmentation

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge And Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS

    - Abbott
    - American Diagnostica
    - Avocet Medical
    - Axis-Shield
    - Beckman Coulter
    - Becton Dickinson
    - Bio/Data Corporation
    - Biosite
    - Chrono-Log
    - Corgenix Medical
    - Diagnostica Stago
    - Helena Laboratories - HYPEN BioMed
    - Instrumentation Laboratory
    - ITC
    - Nanogen
    - Roche
    - Siemens
    - Sienco
    - Sysmex
    - Thermo Fischer
    - Trinity Biotech
    - ZyCare

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrand's Factor Tests
Worldwide, All Market Segments, Laboratories Performing Coagulation Tests By Country, 2010
Worldwide, All Market Segments, Total Coagulation Test Volume By Country, 2010-2020
Worldwide, All Market Segments, Total Coagulation Reagent Market By Country, 2010-2020
Worldwide, All Market Segments, Total Coagulation Instrument Market By Country, 2010-2020
Worldwide, All Market Segments, Total Coagulation Diagnostics Market By Country, 2010-2020
Executive Summary Table: U.S.A., Total Coagulation Diagnostics Market By Market Segment and Product Category, 2010-2020
U.S.A., Laboratories Performing Coagulation Tests By Market Segment, 2010
U.S.A., Hospital Laboratories Performing Coagulation Tests By Bed Size, 2010
U.S.A., Commercial/Private Laboratories Performing Coagulation Tests By Annual Test Volume, 2010
U.S.A., Physician Offices/Group Practices Performing Coagulation Tests By Practice Size, 2010
U.S.A., Hospital Laboratories Average Daily Test Volume, 2010
U.S.A., Commercial/Private Laboratories Average Daily Test Volume, 2010
U.S.A., Physician Offices/Group Practices Average Daily Test Volume
U.S.A., Total Coagulation Test Volume By Market Segment, 2010-2020
U.S.A., All Market Segments Coagulation Test Volume, 2010-2020
U.S.A., Hospital Laboratories Coagulation Test Volume, 2010-2020
U.S.A., Physician Offices/Group Practices Coagulation Test Volume, 2010-2020
U.S.A., Commercial/Private Laboratories Coagulation Test Volume, 2010-2020
U.S.A., Coagulation Reagent Market By Market Segment, 2010-2020
U.S.A., Major Suppliers of Coagulation Reagents Estimated Sales and Market Shares, 2010
U.S.A., Coagulation Instrument Market By Market Segment, 2010-2020
U.S.A., Major Suppliers of Coagulation Analyzers, Estimated Total Instrument Placements and Market Shares, 2010
U.S.A., Major Suppliers of Coagulation Analyzers, Estimated Placements and Installed Base By Supplier and Model, 2010
U.S.A., Major Suppliers of Coagulation Analyzers, Estimated Instrument Sales and Market Shares, 2010
U.S.A., Total Coagulation Diagnostics Market By Product Category, 2010-2020
U.S.A., Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares, 2010